Skip to content

Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.

Meta-analysis · Eur J Endocrinol · 2023. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 37474112

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.

Lin DS, Yu AL, Lo HY et al.
Eur J Endocrinol · 2023

PubMed ID
37474112
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.